Overview

A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

Status:
Completed

Trial end date:
2017-08-21

Target enrollment:

Participant gender:

Summary

To compare the therapeutic effect of tacrolimus in combination with low-dose corticosteroid with high-dose corticosteroid alone in patients with minimal-change nephrotic syndrome.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Korea, Inc.

Treatments:

Prednisolone
Tacrolimus